chr22-23693813-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_153615.2(RGL4):āc.751G>Cā(p.Gly251Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,614,128 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_153615.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGL4 | NM_153615.2 | c.751G>C | p.Gly251Arg | missense_variant | 4/11 | ENST00000290691.10 | NP_705843.1 | |
RGL4 | NM_001329424.3 | c.751G>C | p.Gly251Arg | missense_variant | 4/12 | NP_001316353.1 | ||
GUSBP11 | NR_024448.2 | n.2561+306C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGL4 | ENST00000290691.10 | c.751G>C | p.Gly251Arg | missense_variant | 4/11 | 1 | NM_153615.2 | ENSP00000290691.5 | ||
RGL4 | ENST00000441897.5 | n.751G>C | non_coding_transcript_exon_variant | 6/14 | 2 | ENSP00000396252.1 |
Frequencies
GnomAD3 genomes AF: 0.000657 AC: 100AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251416Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135898
GnomAD4 exome AF: 0.0000746 AC: 109AN: 1461834Hom.: 1 Cov.: 34 AF XY: 0.0000743 AC XY: 54AN XY: 727226
GnomAD4 genome AF: 0.000663 AC: 101AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000739 AC XY: 55AN XY: 74470
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at